While promoter methylation of BRCA1 is frequently observed across cancers, BARD1 promoter methylation is comparatively rare, suggesting that preservation of BARD1 expression may contribute to its tumor suppressor function [89,90,91,92]. The gene discussed is BRCA1; the disease is neoplasm.